View original post here: Alvotech Provides Update on Status of Biologics License Applications for AVT02 and AVT04
View original post here: Alvotech Provides Update on Status of Biologics License Applications for AVT02 and AVT04
See more here: Apollomics Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
Read this article: Information on the Total Number of Voting Rights (Denominator) following Conversion Notices from Atlas
Read the original: BridgeBio Pharma Secures up to $1.25 Billion of Capital from Blue Owl and CPP Investments to Accelerate the Development and Launch of Genetic...
View post: TScan Therapeutics Announces Best Abstracts Award and Upcoming Oral Presentation at the 2024 Tandem Meetings of ASTCT and CIBMTR
See original here: Processa Pharmaceuticals to Effect a 1-for-20 Reverse Stock Split
Link: Beyond Air® Schedules Third Fiscal Quarter 2024 Financial Results Conference Call and Webcast
Go here to read the rest: aTyr Pharma Announces Howard University President Emeritus Dr. Wayne A. I. Frederick as Advisor
See more here: Korro Bio Highlights Data for its Lead Program in Alpha-1 Antitrypsin Deficiency (AATD) and Progress Across its RNA Editing Portfolio
The rest is here: Kizoo leads financing round in Reservoir Neuroscience to restore health to the aging brain
Recent Comments